JUST IN: EU Authorizes Remdesivir For Covid-19 Treatment

The European Union has approved
Remdesivir as medication for Covid-19, across member states.

“We have authorised the first medicine, Remdesivir, to treat #coronavirus at EU level,” EU tweeted on Friday.

EU noted that the drug had been cleared and recommended by the
European Medicines Agency (EMA).

“This conditional marketing authorisation comes less than a month after the application was submitted, supported by @EMA_News and EU countries,” it tweeted.

On her part,EU Health Commissioner Stella Kyriakides said the development was one step forward in the fight against covid-19.

“We will leave no stone unturned in our efforts to secure efficient treatments or vaccine against the coronavirus,” she tweeted.

We have authorised the first medicine, Remdesivir, to treat #coronavirus at EU level.

This conditional marketing authorisation comes less than a month after the application was submitted, supported by @EMA_News and EU countries.

More: https://t.co/PW7P76VzXN #StrongerTogether pic.twitter.com/U3LvRpkUpp

— European Commission ?? (@EU_Commission) July 3, 2020

This is an important step forward in our efforts against #COVID19. We will leave no stone unturned to provide our citizens with access to safe and effective therapeutics ? https://t.co/EoCEyjsPHT

— Stella Kyriakides (@SKyriakidesEU) July 3, 2020